By lowering SOD1 protein levels in cerebrospinal fluid (CSF) and blood, tofersen helps slow disease progression and improves the quality of life for patients with SOD1-related ALS [103,104]. Here, SOD1 is linked to amyotrophic lateral sclerosis.